5th Jan 2015 14:26
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of changes in the Directors' interests in the Ordinary Shares and American Depositary Shares (ADSs) of GlaxoSmithKline plc.
On 31 December 2014, the Company's Non-Executive Directors were allocated notional Ordinary Shares at a price of £13.84 per Ordinary Share, and notional ADSs at a price of $42.91 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 October 2014 to 31 December 2014:
Non Executive Director | Ordinary Shares | No. of ADSs |
Sir Christopher Gent | 4,515.896 | |
Professor Sir Roy Anderson | 519.328 | |
Dr Stephanie Burns | 683.943 | |
Stacey Cartwright | 383.851 | |
Lynn Elsenhans | 1,231.098 | |
Judy Lewent | 530.646 | |
Sir Deryck Maughan | 1,367.886 | |
Dr Daniel Podolsky | 1,238.173 | |
Tom de Swaan | 474.169 | |
Jing Ulrich | 341.972 | |
Hans Wijers | 383.851 |
The Company and the Non-Executive Directors were informed of these allocations on 5 January 2014.
This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Company Secretary
5 January 2015
Related Shares:
Glaxosmithkline